Gefitinib in a molecularly defined chemonaive population with advanced non-small-cell lung cancer

被引：1
|
作者：
Teck, Lim Wan [1 ]
Huat, Tan Bee [1 ]
Ravindran, Kanesvaran [1 ]
Balram, Chowbay [1 ]
机构：
[1] Natl Canc Ctr S, Div Med Sci, Clin Pharmacol Lab, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
来源：
PHARMACOGENOMICS | 2008年 / 9卷 / 10期
关键词：
D O I：
10.2217/14622416.9.10.1381
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [21] Gefitinib (IRESSA) versus vinorelbine in chemonaive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized Phase II study
    Crino, Lucio
    Zatloukal, Petr
    Reck, Martin
    Pesek, Milos
    Thomson, Joyce
    Ford, Hugo
    Hirsch, Fred
    Duffield, Emma
    Armour, Alison
    Cullen, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S341 - S341
  • [22] Molecularly Targeted Therapies in Locally Advanced Non-Small-Cell Lung Cancer
    Devarakonda, Siddhartha
    Morgensztern, Daniel
    Govindan, Ramaswamy
    CLINICAL LUNG CANCER, 2013, 14 (05) : 467 - 472
  • [23] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    Cappuzzo, F
    Magrini, E
    Ceresoli, GL
    Bartolini, S
    Rossi, E
    Ludovini, V
    Gregorc, V
    Ligorio, C
    Cancellieri, A
    Damiani, S
    Spreafico, A
    Paties, CT
    Lombardo, L
    Calandri, C
    Bellezza, G
    Tonato, M
    Crinò, L
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1133 - 1141
  • [24] Gefitinib - A review of its use in the management of advanced non-small-cell lung cancer
    Frampton, JE
    Easthope, SE
    DRUGS, 2004, 64 (21) : 2475 - 2492
  • [25] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer
    C Gridelli
    P Maione
    V Castaldo
    A Rossi
    British Journal of Cancer, 2003, 89 : 1827 - 1829
  • [26] EFFECTIVENESS OF ERLOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER AFTER FAILURE OF GEFITINIB
    Saito, Haruhiro
    Murakami, Shuji
    Honda, Takeshi
    Kondo, Tetsuro
    Oshita, Fumihiro
    Noda, Kazumasa
    Yamada, Kouzo
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [27] Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer
    Rossi, Antonio
    La Salvia, Anna
    Di Maio, Massimo
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (03) : 171 - 180
  • [28] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    De Braud, F
    De Pas, T
    Spaggiari, L
    Veronesi, G
    Curigliano, G
    Noberasco, C
    Pelosi, G
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 461 - 462
  • [29] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer
    Gridelli, C
    Maione, P
    Castaldo, V
    Rossi, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1827 - 1829
  • [30] Regression of metastatic non-small-cell lung cancer in a chemonaive patient treated with gefitinib ('Iressa', ZD1839)
    Petruzelka, L
    Zemanova, M
    BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
12345